Turbogen director holds options for 30,177 shares
Turbogen Ltd. (TRBG) reported that director Shitrit Idan Ben holds options to purchase 30,177 ordinary shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Turbogen Ltd. (TRBG) reported that director Shitrit Idan Ben holds options to purchase 30,177 ordinary shares. These options were granted on March 9, 2025, at an exercise price of $2.99 per share and expire on March 9, 2032.
The grant vests in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested, and none have been exercised into ordinary shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share option (right to buy) F2, F1 | -- | -- | -- |
Footnotes (2)
- F1. A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
- F2. The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.
Key Figures
Key Terms
exercise price financial
vest in three equal installments financial
exchange rate financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider holdings did TRBG director Shitrit Idan Ben report?
What is the exercise price of the options held by the TRBG director?
How many of the TRBG director’s options are vested and exercisable?
When do the reported Turbogen Ltd. options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.